Vivienne Williams

Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Science Foundation Ireland funds oriented basic and applied research in the areas of science, technology, engineering, and mathematics (STEM). It promotes and supports the study of, education in, and engagement with STEM and promotes an awareness and understanding of the value of STEM to society. The company was founded in 1998 and is headquartered in Dublin, Ireland,.

Randox Health London Ltd provides business support services. The private company is located in the UK.

Part of TQ360 (HC) Ltd., TQ360 Ltd. is a British company that provides business support services. The company is based in Glasgow, UK and was founded in 2011.

Part of Randox Holdings Ltd., Randox Food Diagnostics Ltd. is a British company that provides laboratory testing services. The company is based in Crumlin, UK.

Randox Laboratories Ltd. provides clinical diagnostic solutions to laboratories. It develops, manufactures and markets high quality diagnostic reagents and equipment for laboratory medicine. The firm's products include Biochip Array Technology, clinical chemistry analyzers and reagents, quality control materials and schemes and an extensive life science portfolio. The company was founded by Peter FitzGerald in April 1982 and is headquartered in Crumlin, the United Kingdom.

Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ.

Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.

IdentiGEN Ltd. provides DNA-based food tracking and labeling solutions to the agri-food industry. The company was founded by Ciaran Meghen, Ronan Loftus, and Patrick J. Cunningham in 1996 and is headquartered in Dublin, Ireland.

Luxcel Biosciences Ltd. develops, manufactures, and distributes optical fluorescence test solutions for application in the pharmaceutical and food safety industries. It offers MitoXpress Xtra oxygen consumption assay, MitoXpress stress test, MitoXpress FAO assay, pH-Xtra Glycolysis assay, and pH-Xtra Glycolysis stress test. The company was founded by Richard Fernandes and Dmitri Papkovsky in 2002 and is headquartered in Cork, Ireland.

GK Technologies, Inc. manufactures wire and cable products, electronic and electrical circuit components, and environmental products. The company is headquartered in Woodcliff Lake, NJ.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.